Rapid Micro Biosystems announced the Seeing the Growth Direct System, which brings its capabilities to life and highlights the true possibilities of automated rapid microbial testing.

Rapid Micro Biosystems is a life sciences technology company providing automation solutions that improve the manufacturing process and enable the fast, safe release of critical healthcare products like biologics, vaccines, cell and gene therapies, and sterile injectables. We are a trusted partner in quality control microbiology automation, helping customers enhance lives and improve patient outcomes. Our vision is realized through the Growth Direct® System. The Growth Direct® platform replaces outdated, manual microbiology testing in large pharmaceutical manufacturing operations worldwide. By bringing quality control directly to the manufacturing floor, Growth Direct® enables faster, more accurate results, greater efficiency, and improved compliance with data integrity standards. These benefits help our customers make quicker, more informed decisions and ensure a reliable supply of vital healthcare products. Our company values guide us in achieving our vision: • Customer-Driven: We are committed to delivering high-quality products and services. • Respect: We embrace diversity and foster trust within our teams. • Grit: We face challenges with determination and find solutions. • One RMB: We work together as one unified team, driven by a shared purpose. The company is headquartered in Lexington, Massachusetts, and has U.S. manufacturing in Lowell, Massachusetts, and global locations in Switzerland, Germany, and the Netherlands.